| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/28/2005 | US20050089860 Oligonucleotide sequences free from mishybridization and method of designing the same |
| 04/28/2005 | US20050089859 Method for the isolation of nucleic acids |
| 04/28/2005 | US20050089856 Using variation in polymerase chain reaction products as diagnostic tool in identifying hydrolase variants; identifying agents for prevention and treatment of epilepsy, nervous system and cardiovascular disorders |
| 04/28/2005 | US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders |
| 04/28/2005 | US20050089853 Method |
| 04/28/2005 | US20050089846 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 04/28/2005 | US20050089844 Novel dual oxidases as mitogenic and endocrine regulators |
| 04/28/2005 | US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases |
| 04/28/2005 | US20050089841 Induction of a Th1-like response in vitro |
| 04/28/2005 | US20050089538 Carcinoembryonic antigen (CEA); administering a humanized Class III, anti-CEA, monoclonal antibody to treat cancer; complementarity-determining regions (CDR) of given amino acid sequences; diagnostic and therapeutic conjugates; transformed cells |
| 04/28/2005 | US20050089532 Method of protein production using mitochondrial translation system |
| 04/28/2005 | US20050089531 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome |
| 04/28/2005 | US20050089527 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |
| 04/28/2005 | US20050089526 Monomeric unit of the complex containin HIV-1 gp120 and HIV-1 gp41, (ii) the gp4l has one or more mutations in its N-terminal helix, and (iii) the gp120 and gp41 are bound to each other by a disulfide bond between a cysteine residue introduced into the gp120 and a cysteine residue introduced into gp41 |
| 04/28/2005 | US20050089522 Treating a bone cancer patient with a monoclonal antibody that specifically binds a RANK (receptor activator of NF- kappa B) polypeptide with specific amino acid sequence for inhibiting RANK-induced osteoclastogenesis |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089519 Bispecific anti-cd19x anti-cd16 antibodies and uses thereof |
| 04/28/2005 | US20050089515 Poly-pegylated protease inhibitors |
| 04/28/2005 | US20050089511 Methods and compositions comprising DNA damaging agents and p53 |
| 04/28/2005 | US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation |
| 04/28/2005 | US20050089493 Spermine peptide surfactants with amide or amine bonds for surfactants used to transfer cells |
| 04/28/2005 | US20050089447 Base sequence detecting electrode, base sequence detecting device and base sequence detecting method |
| 04/28/2005 | CA2762955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/28/2005 | CA2548551A1 Shc proteins as therapeutic targets in proliferative diseases |
| 04/28/2005 | CA2543447A1 Antibody and use of the same |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542791A1 Flp-mediated recombination |
| 04/28/2005 | CA2542787A1 Method and kit for primer based multiplex amplification of nucleic acids |
| 04/28/2005 | CA2542765A1 Method of inhibiting secretase activity |
| 04/28/2005 | CA2542674A1 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/28/2005 | CA2542639A1 Novel heat shock protein 20-related polypeptides and uses therefor |
| 04/28/2005 | CA2542618A1 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | CA2542478A1 Method for the dissociation of the extracellular haemoglobin molecule of arenicola marina and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 04/28/2005 | CA2542451A1 Methods and compositions for altering seed phenotypes |
| 04/28/2005 | CA2542417A1 Methods and compositions for the treatment of neurological disease |
| 04/28/2005 | CA2542337A1 Cancer gene therapeutic drug |
| 04/28/2005 | CA2542335A1 Cancer gene therapeutic drug |
| 04/28/2005 | CA2542281A1 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 04/28/2005 | CA2542269A1 Fusion molecules comprising antigens and mhc i or ii cytoplasmic domains |
| 04/28/2005 | CA2542182A1 Method for identification of suitable fragmentation sites in a reporter protein |
| 04/28/2005 | CA2542155A1 Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
| 04/28/2005 | CA2541911A1 Nucleic acid extraction method |
| 04/28/2005 | CA2541166A1 Site-specific incorporation of redox active amino acids into proteins |
| 04/28/2005 | CA2540985A1 A method of screening for protein secreting recombinant host cells |
| 04/28/2005 | CA2540210A1 Transgenic rodents selectively expressing human b1 bradykinin receptor protein |
| 04/28/2005 | CA2539996A1 Prevention of incorporation of non-standard amino acids into protein |
| 04/28/2005 | CA2538722A1 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 04/28/2005 | CA2536082A1 Therapeutic uses of chemokine variants |
| 04/28/2005 | CA2526691A1 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 04/28/2005 | CA2512431A1 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 04/27/2005 | EP1526187A2 Intraoperative lymph node assay |
| 04/27/2005 | EP1526186A2 Colorectal cancer prognostics |
| 04/27/2005 | EP1526185A1 Use of a microorganism or cell to induce autoimmunization of an organism against a tumor |
| 04/27/2005 | EP1526184A1 Promoter sequences specific for cells of the B lymphoid lineage and pharmaceutical compositions containing the same |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | EP1526182A2 Subtilisin variants |
| 04/27/2005 | EP1526181A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia |
| 04/27/2005 | EP1526179A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia |
| 04/27/2005 | EP1526178A1 MSP-3-like family of genes |
| 04/27/2005 | EP1526177A1 Nucleic acids useful for triggering tumor cell lethality |
| 04/27/2005 | EP1526176A2 Devices and methods for isolating RNA |
| 04/27/2005 | EP1526174A2 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/27/2005 | EP1526173A2 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1526140A1 Novel potassium-dependent sodium-calcium exchanger |
| 04/27/2005 | EP1525881A2 Integrative protein-DNA cochleate fomulations and methods for transforming cells |
| 04/27/2005 | EP1525798A2 Carbohydrate oxidase and use thereof in baking |
| 04/27/2005 | EP1525473A2 Method and device for protein delivery into cells |
| 04/27/2005 | EP1525472A2 Method and device for screening molecules in cells |
| 04/27/2005 | EP1525466A2 Transgenic mammals expressing polyglutamine |
| 04/27/2005 | EP1525465A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 04/27/2005 | EP1525326A1 Analysis of biological samples |
| 04/27/2005 | EP1525325A2 Novel method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht sb 2c /sb receptor |
| 04/27/2005 | EP1525323A2 Pgc-beta, a novel pgc-1 homologue and uses therefor |
| 04/27/2005 | EP1525320A1 Method of expressing recombinant protein in cho cells |
| 04/27/2005 | EP1525319A1 Method for enhancing the nutritive value of plant extract |
| 04/27/2005 | EP1525318A1 Method for enhancing yield of recombinant protein production from plants |
| 04/27/2005 | EP1525317A1 Clubroot resistant brassica oleracea plants |
| 04/27/2005 | EP1525316A2 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 04/27/2005 | EP1525315A1 Method for obtaining the pathogenic resistance in plants |
| 04/27/2005 | EP1525314A2 Multi-reporter gene model for toxicological screening |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525312A2 Brachyspira hyodysenteriae vaccine |
| 04/27/2005 | EP1525311A2 Protein complexes of the tip60 transcriptional activator protein as well as components, fragments and derivatives thereof and methods for using the same |
| 04/27/2005 | EP1525310A2 Cancer therapy by modulating cdc42-activity |
| 04/27/2005 | EP1525309A2 Stabilisation of nucleic acids |
| 04/27/2005 | EP1525307A2 Modified adamts4 molecules and method of use thereof |
| 04/27/2005 | EP1525306A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 04/27/2005 | EP1525304A1 Nadh-dependent cytochrome b5 reductase as a target for herbicides |
| 04/27/2005 | EP1525303A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
| 04/27/2005 | EP1525301A2 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 04/27/2005 | EP1525299A2 Petal-array support for use with microplates |
| 04/27/2005 | EP1525220A1 Splice variant cannabinoid receptor (cb1b) |
| 04/27/2005 | EP1525217A1 Plant peptide with antimicrobial activity |
| 04/27/2005 | EP1525210A2 Method for making biochips |
| 04/27/2005 | EP1525055A1 Lateral flow assay device and method |
| 04/27/2005 | EP1525053A1 Device and method for purification of nucleic acids |
| 04/27/2005 | EP1525052A1 Size-exclusion ion-exchange particles |
| 04/27/2005 | EP1525047A2 Device for fast vibration of tubes containing samples |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |